CXCL10+ T cells and NK cells assist in the recruitment and activation of CXCR3+ and CXCL11+ leukocytes during Mycobacteria-enhanced colitis

BMC Immunology

Volumn 9, Issue , 2008, Pages

  Singh, Udai P ^a   Singh, Rajesh ^b   Singh, Shailesh ^b   Karls, Russell K ^c   Quinn, Frederick D ^c   Taub, Dennis D ^d   Lillard Jr , James W ^a,b  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G2 ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA; ALPHA CHEMOKINE; BACTERIUM ANTIBODY; CXCL11 PROTEIN, MOUSE; CXCR3 PROTEIN, MOUSE; CYTOKINE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; DENDRITIC CELL; DISEASE COURSE; ENTERITIS; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; LEUKOCYTE ACTIVATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MOLECULAR DYNAMICS; MOUSE; MUCOSA CELL; MYCOBACTERIUM PARATUBERCULOSIS; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; T LYMPHOCYTE; ULCERATIVE COLITIS; ANIMAL; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; MYCOBACTERIUM AVIUM; NEUTROPHIL;

ADULT; ANIMALS; ANTIBODIES, BACTERIAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINE CXCL11; CHEMOKINES, CXC; COLITIS; CYTOKINES; DENDRITIC CELLS; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERFERON TYPE II; INTERLEUKIN-10; KILLER CELLS, NATURAL; MICE; MICE, KNOCKOUT; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; NEUTROPHILS; RECEPTORS, CXCR3; SERUM AMYLOID A PROTEIN; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 48149108373     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-9-25     Document Type: Article

References (41)

1. Chiodini RJ Crohn's disease and the mycobacterioses: A review and comparison of two disease entities Clin Microbiol Rev 1989, 2:90-117 358101 2644025
2. McFadden JJ Butcher PD Chiodini RJ Hermon-Taylor J Determination of genome size and DNA homology between an unclassified Mycobacterium species isolated from patients with Crohn's disease and other mycobacteria J Gen Microbiol 1987, 133:211-4 3655723
3. Autschbach F Eisold S Hinz U Zinser S Linnebacher M Giese T Loffler T Buchler MW Schmidt J High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn's disease Gut 2005, 54:944-9 10.1136/gut.2004.045526 15951539
4. Naser SA Schwartz D Shafran I Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn's disease patients Am J Gastroenterol 2000, 95:1094-5 10.1111/j.1572-0241.2000.01954.x 10763975
5. Hermon-Taylor J Barnes N Clarke C Finlayson C Mycobacterium paratuberculosis cervical lymphadenitis, followed five years later by terminal ileitis similar to Crohn's disease BMJ 1998, 316:449-53 9492675
6. Naser SA Hulten K Shafran I Graham DY El-Zaatari FA Specific seroreactivity of Crohn's disease patients against p35 and p36 antigens of M. avium subsp. paratuberculosis Vet Microbiol 2000, 77:497-504 10.1016/S0378-1135(00)00334-5 11118734
7. Singh UP Singh S Singh R Karls RK Quinn FD Potter ME Lillard JW Jr Influence of Mycobacterium avium subsp. paratuberculosis on colitis development and specific immune responses during disease Infect Immun 2007, 75:3722-8 1952017 17502388 10.1128/IAI.01770-06
8. Fiocchi C Inflammatory bowel disease: Etiology and pathogenesis Gastroenterol 1998, 115:182-205 10.1016/S0016-5085(98)70381-6
9. Singh UP Venkataraman C Singh R Lillard JW Jr CXCR3 axis: Role in inflammatory bowel disease and its therapeutic implication Endocr Metab Immune Disord Drug Targets 2007, 7:111-23 10.2174/187153007780832109 17584151
10. Bonecchi R Bianchi G Bordignon PP D'ambrosio D Lang R Borsatti A Sozzani S Allavena P Gray PA Mantovani A Sinigaglia F Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s J Exp Med 1998, 187:129-34 2199181 9419219 10.1084/ jem.187.1.129
11. Singh UP Singh S Taub DD Lillard JW Jr Inhibition of IFN-gamma-inducible protein-10 abrogates colitis in IL-10(-/-) mice J Immunol 2003, 171:1401-6 12874231
12. Singh UP Singh S Weaver CT Iqbal N McGhee JR Lillard JW Jr IFN-γ-inducible chemokines enhance adaptive immunity and oolitis J Interferon Cytokine Res 2003, 23:591-600 10.1089/107999003322485099 14585199
13. Lillard JW Jr Boyaka PN Taub DD McGhee JR RANTES potentiates antigen-specific mucosal immune responses J Immunol 2001, 166:162-9 11123289
14. + T cells in a transfer model of colitis J Immunol 1998, 161:3256-61 9759840
15. Cassatella MA Gasperini S Calzetti F Bertagnin A Luster AD McDonald PP Regulated production of the interferon-gamma-inducible protein-10 (IP-10) chemokine by human neutrophils Eur J Immunol 1997, 27:111-5 10.1002/eji.1830270117 9022006
16. Olsen I Wiker HG Johnson E Langeggen H Reitan LJ Elevated antibody responses in patients with Crohn's disease against a 14-kDa secreted protein purified from Mycobacterium avium subsp. paratuberculosis Scan J Immunol 2001, 53:198-203 10.1046/j.1365-3083.2001.00857.x
17. El-Zaatari FA Naser SA Hulten K Burch P Graham DY Characterization of Mycobacterium paratuberculosis p36 antigen and its seroreactivities in Crohn's disease Curr Microbiol 1999, 39:115-9 10.1007/s002849900430 10398839
18. Trinchieri G Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes Blood 1994, 84:4008-27 7994020
19. van Deventer SJ Chemokine production by intestinal epithelial cells: A therapeutic target in inflammatory bowel disease? Aliment Pharmacol Ther 1997, 11(Suppl 3):116-20 discussion 120-1. 9467986
20. Mouser JF Hyams JS Infliximab: A novel chimeric monoclonal antibody for the treatment of Crohn's disease Clin Ther 1999, 21:932-42 discussion 931. 10.1016/S0149-2918(99)80015-0 10440618
21. Breese EJ Michie CA Nicholls SW Murch SH Williams CB Domizio P Walker-Smith JA MacDonald TT Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease Gastroenterology 1994, 106(6):1455-66 8194690
22. Reimund JM Wittersheim C Dumont S Muller CD Kenney JS Baumann R Poindron P Duclos B Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease Gut 1996, 39:684-9 1383392 9026483 10.1136/gut.39.5.684
23. Baumgart DC McVay LD Carding SR Mechanisms of immune cell-mediated tissue injury in inflammatory bowel disease Int J Mol Med 1998, 1(2):315-32 9852233
24. Corazza N Eichenberger S Eugster HP Mueller C Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2(-/-) mice upon transfer of CD4(+) CD45RB(hi) T cells J Exp Med 1999, 190:1479-91 2195702 10562322 10.1084/ jem.190.10.1479
25. Sallusto F Lanzavecchia A Mackay CR Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses Immunol Today 1998, 19:568-74 10.1016/S0167-5699(98)01346-2 9864948
26. -/- mice, which can be abrogated by anti-CXCL10 antibody inhibition J Interferon Cytokine Res 2008, 28:31-43 10.1089/jir.2007.0059 18370870
27. +IL-12-IL-18- dendritic cell populations in the colonic mucosa of patients with Crohn's disease Eur J Immunol 2003, 33:143-51 10.1002/immu.200390017 12594843
28. Iwasaki A Kelsall BL Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine J Exp Med 2000, 191:1381-94 2193144 10770804 10.1084/jem.191.8.1381
29. Sozzani S Sallusto F Luini W Zhou D Piemonti L Allavena P Van Damme J Valitutti S Lanzavecchia A Mantovani A Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines J Immunol 1995, 155:3292-95 7561021
30. MacPherson GG Jenkins CD Stein MJ Edwards C Endotoxin-mediated dendritic cell release from the intestine. Characterization of released dendritic cells and TNF dependence J Immunol 1995, 154:1317-22 7822800
31. Dieu-Nosjean MC Vicari A Lebecque S Caux C Regulation of dendritic cell trafficking: A process that involves the participation of selective chemokines J Leukoc Biol 1999, 66:252-62 10449163
32. Taub DD Longo DL Murphy WJ Human interferon-inducible protein-10 induces mononuclear cell infiltration in mice and promotes the migration of human T lymphocytes into the peripheral tissues and human peripheral blood lymphocytes-SCID mice Blood 1996, 87:1423-31 8608232
33. Sasaki S Yoneyama H Suzuki K Suriki H Aiba T Watanabe S Kawauchi Y Kawachi H Shimizu F Matsushima K Asakura H Narumi S Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival Eur J Immunol 2002, 32:3197-205 10.1002/ 1521-4141(200211)32:11<3197::AID-IMMU3197>3.0.CO;2-1 12555665
34. Romagnani S Induction of TH1 and TH2 responses: A key role for the 'natural' immune response? Immunol Today 1992, 13:379-81 10.1016/ 0167-5699(92)90083-J 1418371
35. Verspaget HW Pena AS Weterman IT Lamers CB Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content Gut 1988, 29:223-8 1433298 2831119 10.1136/gut.29.2.223
36. Medzhitov R Preston-Hurlburt P Kopp E Stadlen A Chen C Ghosh S Janeway CA Jr MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways Mol Cell 1998, 2:253-8 10.1016/S1097-2765(00)80136-7 9734363
37. Adachi O Kawai T Takeda K Matsumoto M Tsutsui H Sakagami M Nakanishi K Akira S Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function Immunity 1998, 9:143-50 10.1016/ S1074-7613(00)80596-8 9697844
38. Shi S Nathan C Schnappinger D Drenkow J Fuortes M Block E Ding A Gingeras TR Schoolnik G Akira S Takeda K Ehrt S MyD88 primes macrophages for full-scale activation by interferon-gamma yet mediates few responses to Mycobacterium tuberculosis J Exp Med 2003, 198:987-97 2194223 14517275 10.1084/jem.20030603
39. Trinchieri G Interleukin-12 and the regulation of innate resistance and adaptive immunity Nat Rev Immunol 2003, 3:133-46 10.1038/nri1001 12563297
40. Iwasaki A Medzhitov R Toll-like receptor control of the adaptive immune responses Nat Immunol 2004, 5:987-95 10.1038/ni1112 15454922
41. Veazey RS Taylor HW Horohov DW Krahenbuhl JL Oliver JL 3rd Snider TG 3rd Histopathology of C57BL/6 mice inoculated orally with Mycobacterium paratuberculosis J Comp Pathol 1995, 113:75-80 10.1016/ S0021-9975(05)80071-4 7490340